ES2074950B1 - Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda. - Google Patents

Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.

Info

Publication number
ES2074950B1
ES2074950B1 ES9301973A ES9301973A ES2074950B1 ES 2074950 B1 ES2074950 B1 ES 2074950B1 ES 9301973 A ES9301973 A ES 9301973A ES 9301973 A ES9301973 A ES 9301973A ES 2074950 B1 ES2074950 B1 ES 2074950B1
Authority
ES
Spain
Prior art keywords
vaccine
sow
reproductive
respiratory disease
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9301973A
Other languages
English (en)
Spanish (es)
Other versions
ES2074950A1 (es
Inventor
Duran Juan Plana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zoetis Belgium SA
Original Assignee
Cyanamid Iberica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyanamid Iberica SA filed Critical Cyanamid Iberica SA
Priority to ES9301973A priority Critical patent/ES2074950B1/es
Priority to NL9401414A priority patent/NL194940C/nl
Priority to DK199401028A priority patent/DK173128B1/da
Priority to FR9410722A priority patent/FR2709966B1/fr
Priority to ITTO940713 priority patent/IT1267448B1/it
Priority to DE19944432338 priority patent/DE4432338C2/de
Priority to GB9418775A priority patent/GB2282811B/en
Publication of ES2074950A1 publication Critical patent/ES2074950A1/es
Application granted granted Critical
Publication of ES2074950B1 publication Critical patent/ES2074950B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10051—Methods of production or purification of viral material
    • C12N2770/10052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES9301973A 1993-09-17 1993-09-17 Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda. Expired - Fee Related ES2074950B1 (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ES9301973A ES2074950B1 (es) 1993-09-17 1993-09-17 Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
NL9401414A NL194940C (nl) 1993-09-17 1994-08-31 Virusstam en vaccin ter voorkoming van varkensreproductie- en -respiratiesyndroom.
DK199401028A DK173128B1 (da) 1993-09-17 1994-09-06 Vaccine mod det porcine reproduktions- og respirationssyndrom fremgangsmåde til fremstilling deraf samt en virus og en DNA-
FR9410722A FR2709966B1 (fr) 1993-09-17 1994-09-07 Vaccin pour la prévention du syndrome respiratoire et de la reproduction du porc.
ITTO940713 IT1267448B1 (it) 1993-09-17 1994-09-09 Vaccino per la prevenzione della sindrome riproduttiva e respiratoria porcina.
DE19944432338 DE4432338C2 (de) 1993-09-17 1994-09-10 Impfstoff zur Verhinderung des reproduktiven und respiratorischen Syndroms bei Schweinen
GB9418775A GB2282811B (en) 1993-09-17 1994-09-16 Vaccine for the prevention of porcine reproductive and respiratory syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301973A ES2074950B1 (es) 1993-09-17 1993-09-17 Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.

Publications (2)

Publication Number Publication Date
ES2074950A1 ES2074950A1 (es) 1995-09-16
ES2074950B1 true ES2074950B1 (es) 1996-03-16

Family

ID=8283072

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301973A Expired - Fee Related ES2074950B1 (es) 1993-09-17 1993-09-17 Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.

Country Status (7)

Country Link
DE (1) DE4432338C2 (da)
DK (1) DK173128B1 (da)
ES (1) ES2074950B1 (da)
FR (1) FR2709966B1 (da)
GB (1) GB2282811B (da)
IT (1) IT1267448B1 (da)
NL (1) NL194940C (da)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013152081A1 (en) 2012-04-04 2013-10-10 Zoetis Llc Mycoplasma hyopneumoniae vaccine
EP3508217A1 (en) 2012-04-04 2019-07-10 Zoetis Services LLC Pcv/mycoplasma hyopneumoniae/prrs combination vaccine

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69201441T3 (de) 1991-06-06 2008-12-04 Boehringer Ingelheim Vetmedica Gmbh Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits.
US6042830A (en) * 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
US6592873B1 (en) 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
US5695766A (en) 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
US6773908B1 (en) 1992-10-30 2004-08-10 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US6251397B1 (en) 1992-10-30 2001-06-26 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same
US6380376B1 (en) 1992-10-30 2002-04-30 Iowa State University Research Foundation Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
ES2078187B1 (es) * 1994-05-13 1996-07-16 Cynamid Iberica S A Proteinas recombinantes de prrs, kits de diagnostico y vacunas que contienen dichas proteinas recombinantes.
GB2289279B (en) * 1994-05-13 1998-09-16 Iberica Cyanamid Diagnostic kits and vaccines containing recombinant PRRSV proteins
US5690940A (en) * 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof
EE04741B1 (et) * 1996-03-01 2006-12-15 Schering Corporation Sigade sigimis- ja hingamissündroomi vaktsiin
US5866401A (en) * 1996-03-01 1999-02-02 Schering Corporation Porcine reproductive and respiratory syndrome vaccine
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
EP1882696A3 (en) 1997-05-06 2008-03-05 Boehringer Ingelheim Vetmedica Gmbh PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
CA2290220C (en) 1998-12-22 2013-11-19 Pfizer Products Inc. An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
CA2366072C (en) 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Prrsv vaccines
MXPA01010681A (es) 1999-04-22 2003-08-20 Us Agriculture Vacuna de sindrome respiratorio y reproductiva porcina a base de ja-142 aislado.
RU2232596C1 (ru) * 2002-10-16 2004-07-20 Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных Способ изготовления вирус-вакцины против репродуктивно-респираторного синдрома свиней
RU2007101725A (ru) 2004-06-18 2008-07-27 Риджентс Оф Дзе Юниверсити Оф Миннесота (Us) Идентификация инфицированных вирусом и вакцинированных вирусом организмов
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
HUE025537T2 (en) 2004-12-30 2016-05-30 Boehringer Ingelheim Vetmedica Inc PCV2-immunogenic compositions and methods for preparing such compositions
CA2894069C (en) 2005-06-24 2019-02-26 Regents Of The University Of Minnesota Prrs viruses, infectious clones, mutants thereof, and methods of use
EP1968630B1 (en) 2005-12-29 2018-01-24 Boehringer Ingelheim Vetmedica, Inc. Multivalent pcv2 immunogenic compositions
RU2316346C2 (ru) * 2006-02-20 2008-02-10 Федеральное государственное учреждение "Федеральный центр охраны здоровья животных" (ФГУ "ВНИИЗЖ") Вакцина против репродуктивно-респираторного синдрома свиней эмульсионная инактивированная
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
EP2558118B1 (en) * 2010-04-16 2019-06-05 Universiteit Gent Cross-protecting vaccine for porcine reproductive and respiratory syndrome virus
SG192821A1 (en) 2011-02-17 2013-09-30 Boehringer Ingelheim Vetmed Commercial scale process for production of prrsv
ES2550258T3 (es) 2011-02-17 2015-11-05 Boehringer Ingelheim Vetmedica Gmbh Nueva cepa del PRRSV europea
EP2737059A1 (en) 2011-07-29 2014-06-04 Boehringer Ingelheim Vetmedica GmbH Novel prrs virus inducing type i interferon in susceptible cells
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
WO2014150822A2 (en) 2013-03-15 2014-09-25 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
EA039060B1 (ru) 2013-12-20 2021-11-29 Бёрингер Ингельхайм Ветмедика Гмбх Вариант вируса ppcc, способ его получения с помощью молекулы нуклеиновой кислоты, конструкции днк или клетки и его применение для лечения и профилактики ррсс

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69201441T3 (de) * 1991-06-06 2008-12-04 Boehringer Ingelheim Vetmedica Gmbh Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits.
AU2684792A (en) * 1991-10-14 1993-05-21 Akzo Nobel N.V. Porcine reproductive respiratory syndrome vaccine and diagnostic
FR2686097B1 (fr) * 1992-01-14 1994-12-30 Rhone Merieux Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
KR100374295B1 (ko) * 1993-02-08 2003-12-24 바이엘 코포레이션 돼지생식및호흡증후군바이러스의생육방법과백신에서그의용도

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013152081A1 (en) 2012-04-04 2013-10-10 Zoetis Llc Mycoplasma hyopneumoniae vaccine
EP3508217A1 (en) 2012-04-04 2019-07-10 Zoetis Services LLC Pcv/mycoplasma hyopneumoniae/prrs combination vaccine

Also Published As

Publication number Publication date
ITTO940713A1 (it) 1996-03-09
NL9401414A (nl) 1995-04-18
ITTO940713A0 (it) 1994-09-09
IT1267448B1 (it) 1997-02-05
NL194940B (nl) 2003-04-01
GB2282811B (en) 1998-02-18
DE4432338C2 (de) 1997-10-30
DE4432338A1 (de) 1995-05-04
DK173128B1 (da) 2000-01-31
GB2282811A (en) 1995-04-19
FR2709966A1 (fr) 1995-03-24
GB9418775D0 (en) 1994-11-02
ES2074950A1 (es) 1995-09-16
NL194940C (nl) 2003-08-04
DK102894A (da) 1995-03-18
FR2709966B1 (fr) 1997-05-23

Similar Documents

Publication Publication Date Title
ES2074950B1 (es) Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
ES2165405T3 (es) Cepas de vacuna europeas del virus del sindrome reproductor y respiratorio porcino (prrsv).
MX9204885A (es) Composicion de vacuna que comprende virus del sindrome de infertilidad y respiratorio de los cerdos.
AR032597A1 (es) Uso de antigenos del virus de la gripe inactivado, en la preparacion de vacunas de una sola dosis intranasal; metodo para la profilaxis de enfermedades o de infecciones gripales en pacientes; equipos que comprenden dichas vacunas en dosis unicas y metodo para fabricar vacunas para la gripe para apli
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
MX9603896A (es) Vacuna para la prevencion de enfermedades respiratorias y reproductivas del cerdo, que contiene virus parainfluenza.
ES2164767T3 (es) Formulaciones de propionato de fluticasona.
Wiktor Cell-mediated immunity and postexposure protection from rabies by inactivated vaccines of tissue culture origin
BR0114393A (pt) Uso de uma preparação de vìrus envelopado dividido, método para produzir uma formulação de vacina intranasal, uso de uma preparação de vacina de vìrus envolopado dividido, kit para liberação de uma formulação de vacina intranasal, dispositivo de liberação intranasal, e, método para proteger ou tratar um mamìfero susceptìvel a, ou sofrendo de doença causada por vìrus envelopado
HUP9903822A2 (hu) Polinukleotid-vakcinakészítmény sertések szaporodásbiológiai és légzőszervi kórképei ellen
ES2136088T3 (es) Compuestos inmunogenos con efecto principalmente anti-citoquina, procedimiento de preparacion, composiciones farmaceuticas y kits que los contienen.
ES2170234T3 (es) Vacuna contra el virus prrs (sindrome reproductor y respiratorio porcino).
DK1326636T3 (da) Vaccinesammensætning
CO5540349A2 (es) Preparacion vacunal de virus de influenza inactivado
AR006023A1 (es) Vacuna contra el sindrome reproductivo y respiratorio porcino
BR0111366A (pt) Vacina de poxvìrus recombinante do vìrus da sìndrome respiratória e reprodutiva de porcino (prrsv)
ES2058283T3 (es) Vacuna contra coronavirus canino.
AR004464A1 (es) Un metodo para producir una proteina de capside de papilomavirus
ES2134634T3 (es) Composiciones farmaceuticas y dispositivos para su administracion.
ES2103828T3 (es) Particulas viricas ensambladas y su uso en una vacuna contra una enfermedad rotavirica.
CO5090882A1 (es) Nueva vacuna y procedimiento de uso des transmitidas sexualmente
AR026637A1 (es) Virus atenuados e inocuos de la diarrea virica bovina para uso en vacas gestantes
ES2058100T3 (es) Vacuna combinada.
ES2177535T3 (es) Vacunas contra protozoos intestinales.
ES2100893T3 (es) Procedimiento de preparacion de una vacuna o de un agente toxico.

Legal Events

Date Code Title Description
PC2A Transfer of patent

Owner name: PFIZER ANIMAL HEALTH, S.A.

Effective date: 20121211

FD2A Announcement of lapse in spain

Effective date: 20141120